BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 38553751)

  • 1. Predictors of serious infections in rheumatoid arthritis-a prospective Brazilian cohort.
    de Almeida ALB; Guimarães MFBR; da Costa Pinto MR; Pereira LR; Reis APMG; Bonfiglioli KR; Louzada-Junior P; Giorgi RDN; de Castro GRW; Radominski SC; Brenol CV; Pugliesi A; da Mota LMH; da Rocha Castelar-Pinheiro G
    Adv Rheumatol; 2024 Mar; 64(1):23. PubMed ID: 38553751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors for the 5-year risk of serious infections in patients with rheumatoid arthritis treated with anti-tumour necrosis factor therapy: a cohort study in the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry.
    van Dartel SA; Fransen J; Kievit W; Dutmer EA; Brus HL; Houtman NM; van de Laar MA; van Riel PL
    Rheumatology (Oxford); 2013 Jun; 52(6):1052-7. PubMed ID: 23365147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry.
    Salmon JH; Gottenberg JE; Ravaud P; Cantagrel A; Combe B; Flipo RM; Schaeverbeke T; Houvenagel E; Gaudin P; Loeuille D; Rist S; Dougados M; Sibilia J; Le Loët X; Meyer O; Solau-Gervais E; Marcelli C; Bardin T; Pane I; Baron G; Perrodeau E; Mariette X;
    Ann Rheum Dis; 2016 Jun; 75(6):1108-13. PubMed ID: 26048170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of infection in rheumatoid arthritis.
    Doran MF; Crowson CS; Pond GR; O'Fallon WM; Gabriel SE
    Arthritis Rheum; 2002 Sep; 46(9):2294-300. PubMed ID: 12355476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infection risk in rheumatoid arthritis and spondyloarthropathy patients under treatment with DMARDs, corticosteroids and TNF-α antagonists.
    Germano V; Cattaruzza MS; Osborn J; Tarantino A; Di Rosa R; Salemi S; D'Amelio R
    J Transl Med; 2014 Mar; 12():77. PubMed ID: 24655394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of nonbiologic disease-modifying antirheumatic drugs and risk of infection in patients with rheumatoid arthritis.
    Lacaille D; Guh DP; Abrahamowicz M; Anis AH; Esdaile JM
    Arthritis Rheum; 2008 Aug; 59(8):1074-81. PubMed ID: 18668604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of Subsequent Infection Among Patients Receiving Tumor Necrosis Factor Inhibitors and Other Disease-Modifying Antirheumatic Drugs.
    Accortt NA; Bonafede MM; Collier DH; Iles J; Curtis JR
    Arthritis Rheumatol; 2016 Jan; 68(1):67-76. PubMed ID: 26359948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of a risk score for serious infection in patients with rheumatoid arthritis.
    Crowson CS; Hoganson DD; Fitz-Gibbon PD; Matteson EL
    Arthritis Rheum; 2012 Sep; 64(9):2847-55. PubMed ID: 22576809
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid artrhitis treatment in Brazil: data from a large real-life multicenter study.
    Gomides APM; de Albuquerque CP; Santos ABV; Bértolo MB; Júnior PL; Giorgi RDN; Radominski SC; Resende Guimarães MFB; Bonfiglioli KR; de Fátima Lobato da Cunha Sauma M; Pereira IA; Brenol CV; da Mota LMH; da Rocha Castelar Pinheiro G
    Adv Rheumatol; 2020 Feb; 60(1):16. PubMed ID: 32106881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonserious Infections in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Bechman K; Halai K; Yates M; Norton S; Cope AP; ; Hyrich KL; Galloway JB
    Arthritis Rheumatol; 2021 Oct; 73(10):1800-1809. PubMed ID: 33844458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence, risk factors and validation of the RABBIT score for serious infections in a cohort of 1557 patients with rheumatoid arthritis.
    Thomas K; Lazarini A; Kaltsonoudis E; Voulgari PV; Drosos AA; Repa A; Sali AMI; Sidiropoulos P; Tsatsani P; Gazi S; Evangelia A; Boki KA; Katsimbri P; Boumpas D; Fragkiadaki K; Tektonidou MG; Sfikakis PP; Karagianni K; Sakkas LI; Grika EP; Vlachoyiannopoulos PG; Evangelatos G; Iliopoulos A; Dimitroulas T; Garyfallos A; Melissaropoulos K; Georgiou P; Areti M; Georganas C; Vounotrypidis P; Georgiopoulos G; Kitas GD; Vassilopoulos D
    Rheumatology (Oxford); 2021 May; 60(5):2223-2230. PubMed ID: 33295627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Older age at rheumatoid arthritis onset and comorbidities correlate with less Health Assessment Questionnaire-Disability Index and Clinical Disease Activity Index response to etanercept in the RADIUS 2 registry.
    Martin WJ; Shim M; Paulus HE; Chaudhari S; Feng J; Elashoff D; Hahn TJ; Ranganath VK;
    J Clin Rheumatol; 2014 Sep; 20(6):301-5. PubMed ID: 25160011
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.
    Rutherford AI; Subesinghe S; Hyrich KL; Galloway JB
    Ann Rheum Dis; 2018 Jun; 77(6):905-910. PubMed ID: 29592917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained moderate-to-high disease activity and higher Charlson score are predictors of incidental serious infection events in RA patients treated with conventional disease-modifying anti-rheumatic drugs: a cohort study in the treat-to-target era.
    Galicia-Hernández G; Parra-Salcedo F; Ugarte-Martínez P; Contreras-Yáñez I; Ponce-de-León A; Pascual-Ramos V
    Clin Exp Rheumatol; 2016; 34(2):261-9. PubMed ID: 26939612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and risk factors for serious infection in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety.
    Komano Y; Tanaka M; Nanki T; Koike R; Sakai R; Kameda H; Nakajima A; Saito K; Takeno M; Atsumi T; Tohma S; Ito S; Tamura N; Fujii T; Sawada T; Ida H; Hashiramoto A; Koike T; Ishigatsubo Y; Eguchi K; Tanaka Y; Takeuchi T; Miyasaka N; Harigai M;
    J Rheumatol; 2011 Jul; 38(7):1258-64. PubMed ID: 21498482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the long-term outcome for patients with rheumatoid arthritis with persistent moderate disease activity or disease remission during the first year after diagnosis: data from the ESPOIR cohort.
    Combe B; Logeart I; Belkacemi MC; Dadoun S; Schaeverbeke T; Daurès JP; Dougados M
    Ann Rheum Dis; 2015 Apr; 74(4):724-9. PubMed ID: 24399234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Undetectable Mannose Binding Lectin and Corticosteroids Increase Serious Infection Risk in Rheumatoid Arthritis.
    Carroll GJ; Makin K; Garnsey M; Bulsara M; Carroll BV; Curtin SM; Allan EM; McLean-Tooke A; Bundell C; Kemp ML; Deshpande P; Ihdayhid D; Coleman S; Easter T; Triplett J; Disteldorf T; Marsden CH; Lucas M
    J Allergy Clin Immunol Pract; 2017; 5(6):1609-1616. PubMed ID: 28634103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The REAL study: a nationwide prospective study of rheumatoid arthritis in Brazil.
    da Rocha Castelar-Pinheiro G; Vargas-Santos AB; de Albuquerque CP; Bértolo MB; Júnior PL; Giorgi RDN; Radominski SC; Resende Guimarães MFB; Bonfiglioli KR; Sauma MFLDC; Pereira IA; Brenol CV; Coutinho ESF; da Mota LMH
    Adv Rheumatol; 2018 Jun; 58(1):9. PubMed ID: 30657089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical predictors of remission and low disease activity in Latin American early rheumatoid arthritis: data from the GLADAR cohort.
    Gamboa-Cárdenas RV; Ugarte-Gil MF; Loreto M; Sacnun MP; Saurit V; Cardiel MH; Soriano ER; Pisoni C; Galarza-Maldonado CM; Rios C; Radominski SC; Castelar-Pinheiro GDR; Bianchi WA; Appenzeller S; da Silveira IG; de Freitas Zerbini CA; Caballero-Uribe CV; Rojas-Villarraga A; Guibert-Toledano M; Ballesteros F; Montufar R; Vázquez-Mellado J; Esquivel-Valerio J; De La Torre IG; Barile-Fabris LA; Palezuelos FI; Andrade-Ortega L; Monge P; Teijeiro R; Achurra-Castillo ÁF; Esteva Spinetti MH; Alarcón GS; Pons-Estel BA
    Clin Rheumatol; 2019 Oct; 38(10):2737-2746. PubMed ID: 31161486
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment and nontreatment predictors of health assessment questionnaire disability progression in rheumatoid arthritis: a longitudinal study of 18,485 patients.
    Michaud K; Wallenstein G; Wolfe F
    Arthritis Care Res (Hoboken); 2011 Mar; 63(3):366-72. PubMed ID: 21080449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.